Also listed on Sarcode Bioscience Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Collateral for a security interest recorded Dec 23, 2025 (JPMorgan Chase Bank, N.A.).
Term ends May 9, 2029 · High confidence
20-year base term ended May 17, 2026
Held by Bausch + Lomb Ireland Limited
Filed May 17, 2006 as application 11/436,906 · Granted May 1, 2012
Base term plus 1088 days of patent term adjustment (USPTO delay)
Today
2006
2029
Clock starts
May 17, 2006
May 17, 2006
Term ends
May 9, 2029
May 9, 2029
Granted
May 1, 2012
May 1, 2012
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,088
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
35
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1088 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 17, 2006, when this application, 11/436,906, was filed | May 17, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1088 days, USPTO patent term adjustment record | May 9, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 9, 2029 | High confidence |
This family
| US 8,168,655 | this patent May 2029 | May 2029 |
| Application 12/508,311 | Abandoned not computed | not computed |
| US 8,084,047 | Term ended May 2026 | May 2026 |
| US 8,771,715 | Term ended May 2026 | May 2026 |
| US 8,758,776 | Term ended Nov 2024 | Nov 2024 |
| US 8,592,450 | Term ended no later than May 2026 | no later than May 2026 |
| Application 13/962,440 | Abandoned not computed | not computed |
| Application 13/962,369 | Abandoned not computed | not computed |
8 of 35 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 21, 2006 Reel 18155, frame 742 | Gadek, Thomas; Burnier, John | Sarcode Corporation | Assignment of Assignor's Interest |
| Oct 25, 2007 Reel 20015, frame 331 | Sarcode, A California Corporation | Sarcode Corporation, A Delaware Corporation | Merger |
| Dec 5, 2007 Reel 20217, frame 751 | Gadek, Thomas; Burnier, John | Sarcode | Correction to Assignee Recorded on Reel 018155 Frame 0742 |
| Sep 8, 2011 Reel 26876, frame 312 | Sarcode Corporation | Sarcode Bioscience Inc. | Change of Name |
| Feb 8, 2013 Reel 29778, frame 888 | Sarcode Bioscience Inc. | Silicon Valley Bank | Security Agreement |
| Feb 13, 2013 Reel 29804, frame 51 | Sarcode, A California Corporation | Sarcode Corporation, a Corporation of State of Delaware | Merger |
| Apr 25, 2013 Reel 30295, frame 28 | Silicon Valley Bank | Sarcode Bioscience Inc. | Release of Security Interest |
| Oct 31, 2019 Reel 50900, frame 268 | Sarcode Bioscience Inc. | Novartis AG | Assignment of Assignor's Interest |
| Oct 22, 2020 Reel 54134, frame 708 | Novartis AG | Novartis Pharmaceuticals Corporation | Assignment of Assignor's Interest |
| Dec 6, 2023 Reel 65789, frame 853 | Novartis Pharmaceuticals Corporation | Bausch + Lomb Ireland Limited | Assignment of Assignor's Interest |
| Dec 23, 2025 Reel 74050, frame 573 | Bausch + Lomb Ireland Limited | JPMorgan Chase Bank, N.A., as Collateral Agent | Intellectual Property Security Agreement |
| Dec 23, 2025 Reel 74050, frame 709 | Bausch + Lomb Ireland Limited | Citibank, N.A., as Notes Collateral Agent | Intellectual Property Security Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2029
Term ends May 9, 2029. No further fees fall due before then
Note
The 1088 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
132
later US patents cite this one
That is top 5% of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.